Mr. Jim Breslin:

Yes. We have worked with the Revenue Commissioners. Where we are trying to fast-track products through a port because of their sensitive nature, we have an advance-notice arrangement with the Revenue Commissioners so their inspections or delays on their end will not apply. More generally, as we have explored, in many situations we do not have single-supplier products. In many circumstances, as in the context of therapeutics, different types of products can be used, depending on availability. We currently manage this. Where a shortage arises in respect of a particular proprietary product, we consider alternatives or different sourcing mechanisms. We also have the ability within our system to make sure that whatever product we do hold in Ireland is used in the most effective way possible. The HPRA will have experience of our running into a supply shortage for a period, although not of circumstances in which we do not have any product. The important point is that all the product be available, and available for the most effective use. It is important not to have products not being used.